Literature DB >> 6198405

From the National Institutes of Health. Summary of a meeting on the origin of pandemic influenza viruses.

W G Laver, R G Webster, C M Chu.   

Abstract

Influenza type A virus periodically undergoes major antigenic shifts in which the hemagglutinin (HAG) and sometimes the neuraminidase (NA) antigens are replaced by HAG and NA antigens of another subtype. Three such shifts have taken place since the virus was first isolated, and all appear to have occurred in China. The way in which these "new" influenza type A viruses suddenly appear (or reappear) in the human population is not known. At a meeting held in Beijing, China, on November 10-12, 1982, participants discussed the latest findings on the molecular biology of influenza viruses and on aspects of their ecology that may offer insight into the factors responsible for the origin of pandemic influenza viruses. Information obtained in earlier studies has provided some clues about how the antigenic shifts may occur. For example, the H3N2 virus has been found to be a recombinant deriving seven of its eight genes from an H2N2 strain and gene 4 (which encodes for the HAG) from some other virus, possibly an avian influenza virus of the H3 subtype [1-3]. In addition, studies of the genome of the H1N1 virus that appeared in Anshan, China, in 1977 have shown that this virus almost certainly underwent no replication for 27 years. This finding suggests that the virus existed in an animal reservoir during this period [4, 5].

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198405     DOI: 10.1093/infdis/149.1.108

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

Review 1.  A new concept of the epidemic process of influenza A virus.

Authors:  R E Hope-Simpson; D B Golubev
Journal:  Epidemiol Infect       Date:  1987-08       Impact factor: 2.451

Review 2.  New aspects of influenza viruses.

Authors:  M W Shaw; N H Arden; H F Maassab
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

3.  Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China.

Authors:  Weizheng Yan; Baoying Huang; Li Ruan; Wenjie Tan
Journal:  Protein Cell       Date:  2017-09       Impact factor: 14.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.